Clinical Trial Update: Platelet Transfusions in Hematopoietic Stem Cell Transplantation (The PATH III Trial) [Phase 3]

View source ↗

Summary

The PATH III trial is a Phase 3 study evaluating platelet transfusions in hematopoietic stem cell transplantation and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Neoplasms

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: Hematologic Neoplasms | Phase 3 | Status: RECRUITING